Log in

Start free trial
Home 5 Lab Industry Advisor 5 Essential 5 FDA Watch: Agency Takes Steps to Downgrade Some Nucleic Acid-Based Tests to Class II

FDA Watch: Agency Takes Steps to Downgrade Some Nucleic Acid-Based Tests to Class II

by | Dec 29, 2025 | Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

The change is expected to dramatically cut the costs of developing new tests

The FDA plans to reclassify some nucleic acid-based tests
FDA - Food and Drug Administration logo on phone screen

Subscribe to view Essential

Start a Free Trial for immediate access to this article

TRY FOR FREE